Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-432841
Filing Date
2013-11-07
Accepted
2013-11-07 16:15:13
Documents
9
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d589109d10q.htm 10-Q 521316
2 EX-31.1 d589109dex311.htm EX-31.1 6234
3 EX-32.1 d589109dex321.htm EX-32.1 2801
  Complete submission text file 0001193125-13-432841.txt   3568815

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ogxi-20130930.xml EX-101.INS 427726
5 XBRL TAXONOMY EXTENSION SCHEMA ogxi-20130930.xsd EX-101.SCH 34746
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ogxi-20130930_cal.xml EX-101.CAL 50453
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ogxi-20130930_def.xml EX-101.DEF 119988
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogxi-20130930_lab.xml EX-101.LAB 303219
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogxi-20130930_pre.xml EX-101.PRE 215402
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 131200803
SIC: 2835 In Vitro & In Vivo Diagnostic Substances